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ABSTRACT
The central hypothesis is that knock-in mice lines are made for two human cohort-specific missense mutations will develop breast cancer with dominant inheritance in a subset of animals. It also is hypothesized that other cancers will be more frequent as well. If correct, it follows that the ATM gene is the first known example of a "sup-oncogene", i.e., a tumor suppressor gene for lymphoma /leukemia and an oncogene for breast cancer. More generally, it is hypothesized that an increased risk for breast cancer due to ATM mutations most commonly derives from cohort-specific missense mutation, that do not cause A-T in a homozygous state and occasionally from a subset of A-T carriers that have non-truncating mutations. Two in human cohort-specific missense variants from our previous case-control analysis will be generated in mice using mouse knock-in technology. The rate and time course of cancer incidence will be determined in these mice in comparison to wild type littermates and an A-T-causing non-truncating structural variant. Since the mouse Atm gene is extremely close to the human gene in structure and function, mouse models with only a single alteration in the gene can be used to assess the effects of this alteration on tumor formation, especially mammary tumors, in mice. If a variety of uncommon missense variants are shown to predispose to breast cancer, there are important diagnostic, preventive, and therapeutic I implications for women at risk for breast cancer.
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